Viking Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $6.7M | $15.4M | $768.6K |
| FY2016 | $6.5M | $14.5M | $3.1M |
| FY2017 | $8.7M | $22.1M | $9.0M |
| FY2018 | $4.6M | $302.3M | $24.8M |
| FY2019 | $7.1M | $284.3M | $8.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $6.7M | $15.4M | $768.6K |
| FY2016 | $6.5M | $14.5M | $3.1M |
| FY2017 | $8.7M | $22.1M | $9.0M |
| FY2018 | $4.6M | $302.3M | $24.8M |
| FY2019 | $7.1M | $284.3M | $8.4M |